Catalog: | C-EL-1881T |
Product Type: | Test kit |
Size: | 96 tests |
Principle: | Solid Phase Sandwich ELISA |
Conjugation: | HRP |
Species: | Human |
Detection range: | 10.94-700 pg/mL |
Sensitivity: | 5.56 pg/mL |
Specificity: | Recognizes both recombinant and natural Human PD-L1 |
Interference: | Preparations of the factors listed below at 50 ng/mL in a mid-range recombinant human PD-L1 control were assayed for interference. No significant interference was observed. |
Sample type: | Serum,Cell supernatant,Plasma |
Test type: | Quantitative |
Analysis mode: | ELISA |
Shipping: | This ELISA Kit is shipped at ambient temperature. |
Storage: | 2-8℃ |
Full name: | CD274 molecule |
Application: | Cancer Drug Targets |
This PD-L1 ELISA Kit, Human is an enzyme-linked immunosorbent assay for the quantitative measurement of Human PD-L1 protein in Serum,Cell supernatant,Plasma . It contains recombinant Human PD-L1, and antibodies raised against the recombinant protein. This ELISA kit is complete and ready-to-use.Programmed death-1 ligand-1 (PD-L1, CD274, B7-H1) has been identified as the ligand for the immunoinhibitory receptor programmed death-1(PD1/PDCD1) and has been demonstrated to play a role in the regulation of immune responses and peripheral tolerance. PD-L1/B7-H1 is a member of the growing B7 family of immune molecules and this protein contains one V-like and one C-like Ig domain within the extracellular domain, and together with PD-L2, are two ligands for PD1 which belongs to the CD28/CTLA4 family expressed on activated lymphoid cells. By binding to PD1 on activated T-cells and B-cells, PD-L1 may inhibit ongoing T-cell responses by inducing apoptosis and arresting cell-cycle progression. Accordingly, it leads to growth of immunogenic tumor growth by increasing apoptosis of antigen specific T cells and may contribute to immune evasion by cancers. PD-L1 thus is regarded as promising therapeutic target for human autoimmune disease and malignant cancers.
Copyright © 2024 Creative Biogene. All rights reserved.